166 related articles for article (PubMed ID: 35234410)
1. From Postoperative to Preoperative: A Case Series of Hypofractionated and Single-Fraction Neoadjuvant Stereotactic Radiosurgery for Brain Metastases.
Udovicich C; Ng SP; Tange D; Bailey N; Haghighi N
Oper Neurosurg (Hagerstown); 2022 Apr; 22(4):208-214. PubMed ID: 35234410
[TBL] [Abstract][Full Text] [Related]
2. A Phase II Study of Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases: Clinical Trial Protocol.
Takami H; Nassiri F; Moraes FY; Zadeh G; Bernstein M; Conrad T; Berlin A; Laperriere N; Millar BA; Shultz DB; Kongkham P
Neurosurgery; 2020 Aug; 87(2):403-407. PubMed ID: 31673708
[TBL] [Abstract][Full Text] [Related]
3. Comparison of preoperative versus postoperative treatment dosimetry plans of single-fraction stereotactic radiosurgery for surgically resected brain metastases.
Cheok SK; Yu C; Feng JJ; Briggs RG; Chow F; Hwang L; Ye JC; Attenello FJ; Tran D; Chang E; Zada G
Neurosurg Focus; 2023 Aug; 55(2):E9. PubMed ID: 37527673
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm.
Li YD; Coxon AT; Huang J; Abraham CD; Dowling JL; Leuthardt EC; Dunn GP; Kim AH; Dacey RG; Zipfel GJ; Evans J; Filiput EA; Chicoine MR
Neurosurg Focus; 2022 Nov; 53(5):E8. PubMed ID: 36321291
[TBL] [Abstract][Full Text] [Related]
6. Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.
Prabhu RS; Miller KR; Asher AL; Heinzerling JH; Moeller BJ; Lankford SP; McCammon RJ; Fasola CE; Patel KR; Press RH; Sumrall AL; Ward MC; Burri SH
J Neurosurg; 2018 Dec; ():1-8. PubMed ID: 30554174
[TBL] [Abstract][Full Text] [Related]
7. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Stereotactic Radiosurgery Before Surgical Resection of Cerebral Metastases.
Patel AR; Nedzi L; Lau S; Barnett SL; Mickey BE; Moore W; Bindal S; Wardak Z; Dan T; Timmerman R; Patel TR
World Neurosurg; 2018 Dec; 120():e480-e487. PubMed ID: 30149167
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S
Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084
[TBL] [Abstract][Full Text] [Related]
11. Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
Johnson MD; Avkshtol V; Baschnagel AM; Meyer K; Ye H; Grills IS; Chen PY; Maitz A; Olson RE; Pieper DR; Krauss DJ
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):537-43. PubMed ID: 26867883
[TBL] [Abstract][Full Text] [Related]
12. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.
Atalar B; Modlin LA; Choi CY; Adler JR; Gibbs IC; Chang SD; Harsh GR; Li G; Nagpal S; Hanlon A; Soltys SG
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):713-8. PubMed ID: 24054875
[TBL] [Abstract][Full Text] [Related]
13. Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases.
Minniti G; Lanzetta G; Capone L; Giraffa M; Russo I; Cicone F; Bozzao A; Alongi F; Nicosia L; Fineschi G; Marchetti L; Tufo T; Bianciardi F; Esposito V; Gentile P; Paolini S
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949695
[TBL] [Abstract][Full Text] [Related]
14. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
15. Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain Metastases.
Soliman H; Myrehaug S; Tseng CL; Ruschin M; Hashmi A; Mainprize T; Spears J; Das S; Yang V; da Costa L; Maralani P; Heyn C; Atenafu EG; Sahgal A
Neurosurgery; 2019 Nov; 85(5):E860-E869. PubMed ID: 31173150
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery.
Huang AJ; Huang KE; Page BR; Ayala-Peacock DN; Lucas JT; Lesser GJ; Laxton AW; Tatter SB; Chan MD
J Neurooncol; 2014 Oct; 120(1):163-9. PubMed ID: 25048529
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases.
Wolf A; Donahue B; Silverman JS; Chachoua A; Lee JK; Kondziolka D
J Neurooncol; 2017 Aug; 134(1):139-143. PubMed ID: 28536993
[TBL] [Abstract][Full Text] [Related]
18. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
[TBL] [Abstract][Full Text] [Related]
19. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
20. A new treatment paradigm: neoadjuvant radiosurgery before surgical resection of brain metastases with analysis of local tumor recurrence.
Asher AL; Burri SH; Wiggins WF; Kelly RP; Boltes MO; Mehrlich M; Norton HJ; Fraser RW
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):899-906. PubMed ID: 24606851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
